This protocol investigates the mechanism of action of Guben Pingchuan granules in bronchial asthma using network pharmacology, molecular docking, and in vivo. validation.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This protocol investigates the mechanism of action of Guben Pingchuan granules in bronchial asthma using network pharmacology, molecular docking, and in vivo. validation.
This study investigates the mechanism of action of Guben Pingchuan granules in the treatment of bronchial asthma using network pharmacology, molecular docking, and experimental validation. Active ingredients and corresponding targets were identified using TCMSP, HERB, and SymMap databases. Bronchial asthma-related targets were collected from GeneCards, OMIM, TTD, DrugBank, and PharmGKB. Overlapping targets were identified, and component–target and protein–protein interaction (PPI) networks were constructed. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed with false discovery rate (FDR) correction. Molecular docking was conducted to evaluate binding affinity, followed by in vivo validation. A total of 121 active components and 234 drug-related targets were identified, yielding 155 overlapping targets. Core targets included TP53, AKT1, TNF, and IL6. KEGG analysis demonstrated significant enrichment of the PI3K–Akt signaling pathway, which was selected for experimental validation. Molecular docking revealed a strong binding affinity between core components and AKT1. In ovalbumin-induced asthmatic rats, Guben Pingchuan granule reduced serum IL-4 and IL-10 levels, increased FoxP3 expression in lung tissue, and upregulated PI3K and AKT mRNA levels. These findings indicate that Guben Pingchuan granule alleviates bronchial asthma by modulating the PI3K–Akt. signaling pathway, regulating inflammatory cytokines, and enhancing regulatory T cell function.
Bronchial asthma is a heterogeneous chronic respiratory disease characterized by airway inflammation, airway hyperresponsiveness, mucus hypersecretion, and airway remodeling1. Its pathogenesis involves complex interactions among immune cell activation, inflammatory mediators, and multiple signaling pathways. Clinically, asthma presents with recurrent wheezing, dyspnea, chest tightness, and cough. Airway inflammation is a central mechanism underlying disease onset and progression, characterized by increased secretion of pro-inflammatory cytokines such as IL-6, IL-4, IL-17, and TNF-α., infiltration of inflammatory cells inc....
Access restricted. Please log in or start a trial to view this content.
All animal procedures were approved by the Animal Ethics Committee of Liaoning University of Traditional Chinese Medicine (Approval No.: 21000042023058) and performed in accordance with institutional guidelines. The research tools used in this protocol are listed in the Table of Materials.
1. Databases and software
2. Acquisition of component targets
Access restricted. Please log in or start a trial to view this content.
Screening of active ingredients
A total of 121 active components were identified from the TCMSP database after filtering for target activity. These included 23 components from Ephedra Herb, 7 from Psoralea, 19 from Apricot seed, 8 from Pseudostellaria root, 16 from Perilla fruit, 18 from Loquat leaf, 7 from Lilium, and 23 from Epimedium. (Table 2). Sixteen common components were identified, including luteolin, quercetin, β-sitosterol, kaem.......
Access restricted. Please log in or start a trial to view this content.
Bronchial asthma is a common disease in the respiratory department16. It is an obstructive airway disorder caused by allergens and airway hyperresponsiveness17. It has a high clinical incidence, is prone to recurrence, and is difficult to cure, significantly affecting patients' health and quality of life. The 2025 Global Initiative for Asthma (GINA) reports that inhaled glucocorticoid therapy is effective for asthma18; however, long-term use may .......
Access restricted. Please log in or start a trial to view this content.
The authors declare no conflict of interest.
The authors thank all colleagues for their assistance. This work was supported by the Liaoning Provincial Department of Education General Project, “Research on the Mechanism of Guben Pingchuan Granules on Airway Inflammation and Immune Regulation in Bronchial Asthma from the Perspectives of Gene Expression Profiling and Metabolomics”; the “Xingliao Talent Program” Medical Expert Project; and the Outstanding Talent in Traditional Chinese Medicine (Clinical) of Liaoning Province.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| qPCR Kit | Novogene | NQ-001, 2×1mL | Detection of relative mRNA expression of target genes |
| aluminum hydroxide Al(OH)3 | Shanghai Yubo Biotechnology Co., LTD | YB-AL001, 500g | Immunological adjuvant to enhance antigen immune response |
| BCA protein Concentration Test Kit | Fode Biotechnology Co., LTD | FD2001, 100 pieces per box | Total protein quantification to standardize sample loading |
| Chemiluminescence imaging system | Tanon | 5200Multi | WB band imaging, gel and blot image collection and analysis |
| Color Pre-stained Protein Marker | Biolaibo Technology Co., LTD | BL005, 10-180kDa, 500μL | Protein molecular weight reference for electrophoresis experiments |
| Enhanced RNA Extraction Kit | Whole Golden Branch | ET111-01v2, 50 pieces per box | Extraction and purification of total RNA from tissues and cells |
| Enzyme-linked immunosorbent assay reader | U.S. Biotek Company | Epoch/BioTek | Quantitative detection of cytokines and protein contents in samples |
| FOXP3 primary antibody | Biyun Tian Biotechnology Co., LTD | AG5002, 50ul/piece | Targeted binding to FOXP3 protein for immunoassay |
| Gel Rapid Preparation Kit | Shanghai Yamei | PG212, 30 sets | Rapid preparation of separating gel and stacking gel for electrophoresis |
| masson Staining Kit | Solabao Biotechnology Co., LTD | G1340, 100 tablets | Specific staining for tissue collagen fibers and fibrosis observation |
| OVA | Beijing Boaotoda Technology Co., LTD. | OVA-10g, ≥98% | Classical allergen for establishing allergic animal models |
| primary Antibody Dilution solution | Biyun Tian Biotechnology Co., LTD | P0256-100ml | Dilute primary antibody, maintain activity and reduce non-specific binding |
| Rat IL-10ELISA Kit | Andy Bio | E-30649, 96T | Quantitative detection of rat IL-10 anti-inflammatory factor |
| Rat IL-4ELISA Kit | Andy Bio | E-30623, 96T | Quantitative detection of rat Th2 inflammatory factor IL-4 |
| Reverse Transcription Kit | Baori Medical Technology Co., LTD | E047-01A | Reverse transcription of RNA into cDNA for subsequent gene analysis |
| Saturated Oil Red O Kit | Solabao Biotechnology Co., LTD | G1261, 50mL×2 bottle | Specific staining and detection of tissue lipid droplets |
| Shangyang Anti-Rabbit Secondary Antibody | Proteintech Biological Co., LTD | SA00001-2, 1mL | Bind to rabbit primary antibody for WB color reaction |
| TBST Buffer | Wuhan Sewell Biotechnology Co., LTD | G2150, 1L / bottle | Buffer for membrane washing and antibody dilution in Western blot |
| Transfer Electrophoresis System | Shanghai Jingcanshi Precision Machinery Co., Ltd. | PowerPac Basic | Used for protein electrophoresis and Western blot membrane transfer |
| Ultra-low temperature refrigerator | Zhongke Meiling | MDF-382 | Low-temperature cryopreservation of reagents, protein samples and tissues |
| Vertical electrophoresis tank | BIO-RAD | JY-ZY5 | Vertical electrophoretic separation of protein and nucleic acid samples |